{"transactions":[{"id":705662,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29477,"kind":"person","name":"DUBIN THOMAS I H","position":1,"cik":"0001231945","reported_name":"DUBIN THOMAS I H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:04:12.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026."}],"balance_after":5500,"derivative":{"exercise_price":4.9,"exercise_date":"2026-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001231945-26-000002","document":"wk-form4_1784577849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231945/000123194526000002/wk-form4_1784577849.xml","form_type":"4"}},{"id":705857,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29553,"kind":"person","name":"Donovan Daniel","position":1,"cik":"0001934188","reported_name":"Donovan Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:03:56.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026."}],"balance_after":5500,"derivative":{"exercise_price":4.9,"exercise_date":"2026-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001934188-26-000002","document":"wk-form4_1784577834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1934188/000193418826000002/wk-form4_1784577834.xml","form_type":"4"}},{"id":705649,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29472,"kind":"person","name":"GOLDBERG MARK A","position":1,"cik":"0001278042","reported_name":"GOLDBERG MARK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:03:40.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026."}],"balance_after":5500,"derivative":{"exercise_price":4.9,"exercise_date":"2026-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001278042-26-000002","document":"wk-form4_1784577818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1278042/000127804226000002/wk-form4_1784577818.xml","form_type":"4"}},{"id":706052,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29601,"kind":"person","name":"Leahy Emer","position":1,"cik":"0001875180","reported_name":"Leahy Emer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:03:18.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026."}],"balance_after":5500,"derivative":{"exercise_price":4.9,"exercise_date":"2026-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001875180-26-000002","document":"wk-form4_1784577796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875180/000187518026000002/wk-form4_1784577796.xml","form_type":"4"}},{"id":705845,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:02:59.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2027."}],"balance_after":11000,"derivative":{"exercise_price":4.9,"exercise_date":"2027-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001895944-26-000008","document":"wk-form4_1784577777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000189594426000008/wk-form4_1784577777.xml","form_type":"4"}},{"id":705626,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:02:39.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2027."}],"balance_after":34000,"derivative":{"exercise_price":4.9,"exercise_date":"2027-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001524547-26-000009","document":"wk-form4_1784577756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454726000009/wk-form4_1784577756.xml","form_type":"4"}},{"id":705663,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:01:00.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026."}],"balance_after":78000,"derivative":{"exercise_price":4.9,"exercise_date":"2026-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001238705-26-000007","document":"wk-form4_1784577657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000123870526000007/wk-form4_1784577657.xml","form_type":"4"}},{"id":721439,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-07-01T20:09:24.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":3688,"price":3.485,"value":12852.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's Amended and Restated 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split."}],"balance_after":7102,"source":{"system":"sec-edgar","filing":"0001895944-26-000006","document":"wk-form4_1782936560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000189594426000006/wk-form4_1782936560.xml","form_type":"4"}},{"id":720761,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-07-01T20:08:22.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1093,"price":3.485,"value":3809.105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's Amended and Restated 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split."}],"balance_after":2239,"source":{"system":"sec-edgar","filing":"0001524547-26-000007","document":"wk-form4_1782936500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454726000007/wk-form4_1782936500.xml","form_type":"4"}},{"id":825154,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-03-30T21:29:06.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":37749,"price":6.11,"value":230646.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted to the Reporting Person as a fully vested stock award under the Issuer's 2021 Stock Incentive Plan in partial satisfaction of the 2025 bonus payment to the Reporting Person in lieu of cash, at the Reporting Person's request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split."}],"balance_after":118549,"source":{"system":"sec-edgar","filing":"0001238705-26-000005","document":"wk-form4_1774901174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000123870526000005/wk-form4_1774901174.xml","form_type":"4"}},{"id":952067,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-01-05T21:03:34.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":8918,"price":0.262,"value":2336.516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."}],"balance_after":85354,"source":{"system":"sec-edgar","filing":"0001895944-26-000003","document":"wk-form4_1767647011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000189594426000003/wk-form4_1767647011.xml","form_type":"4"}},{"id":950307,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-01-05T21:01:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":14482,"price":0.262,"value":3794.284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."}],"balance_after":28661,"source":{"system":"sec-edgar","filing":"0001524547-26-000003","document":"wk-form4_1767646901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454726000003/wk-form4_1767646901.xml","form_type":"4"}},{"id":1095640,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2025-07-02T20:03:00.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":69745,"price":0.261,"value":18203.445,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025."}],"balance_after":76436,"source":{"system":"sec-edgar","filing":"0001567264-25-000066","document":"wk-form4_1751486573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000156726425000066/wk-form4_1751486573.xml","form_type":"4"}},{"id":1094402,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2025-07-02T20:02:22.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":14179,"price":0.261,"value":3700.719,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025."}],"balance_after":14179,"source":{"system":"sec-edgar","filing":"0001567264-25-000065","document":"wk-form4_1751486535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000156726425000065/wk-form4_1751486535.xml","form_type":"4"}},{"id":1157505,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:21:05.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on May 2, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567264-25-000035","document":"wk-form4_1746562857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000156726425000035/wk-form4_1746562857.xml","form_type":"4"}},{"id":1157236,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29477,"kind":"person","name":"DUBIN THOMAS I H","position":1,"cik":"0001231945","reported_name":"DUBIN THOMAS I H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:11:54.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567264-25-000033","document":"wk-form4_1746562305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231945/000156726425000033/wk-form4_1746562305.xml","form_type":"4"}},{"id":1157535,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29553,"kind":"person","name":"Donovan Daniel","position":1,"cik":"0001934188","reported_name":"Donovan Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:11:09.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567264-25-000032","document":"wk-form4_1746562262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1934188/000156726425000032/wk-form4_1746562262.xml","form_type":"4"}},{"id":1157200,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29472,"kind":"person","name":"GOLDBERG MARK A","position":1,"cik":"0001278042","reported_name":"GOLDBERG MARK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:10:04.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567264-25-000031","document":"wk-form4_1746562194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1278042/000156726425000031/wk-form4_1746562194.xml","form_type":"4"}},{"id":1157975,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29601,"kind":"person","name":"Leahy Emer","position":1,"cik":"0001875180","reported_name":"Leahy Emer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:09:05.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567264-25-000030","document":"wk-form4_1746562121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875180/000156726425000030/wk-form4_1746562121.xml","form_type":"4"}},{"id":1157504,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:07:32.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on May 2, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567264-25-000029","document":"wk-form4_1746561910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000156726425000029/wk-form4_1746561910.xml","form_type":"4"}},{"id":1157239,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:07:10.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025."}],"balance_after":700000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001567264-25-000028","document":"wk-form4_1746562022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000156726425000028/wk-form4_1746562022.xml","form_type":"4"}},{"id":1157142,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:03:44.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on May 2, 2025."}],"balance_after":300000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001567264-25-000027","document":"wk-form4_1746561816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000156726425000027/wk-form4_1746561816.xml","form_type":"4"}},{"id":1382412,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-10-23T20:22:28.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":70028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on October 21, 2024."}],"balance_after":70028,"derivative":{"exercise_price":3.44,"expiration_date":"2034-10-21","underlying":"Common Stock","underlying_shares":70028},"source":{"system":"sec-edgar","filing":"0001895944-24-000014","document":"wk-form4_1729714943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000189594424000014/wk-form4_1729714943.xml","form_type":"4"}},{"id":1382323,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-10-23T20:21:12.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":427379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on October 21, 2024."}],"balance_after":427379,"derivative":{"exercise_price":3.44,"expiration_date":"2034-10-21","underlying":"Common Stock","underlying_shares":427379},"source":{"system":"sec-edgar","filing":"0001524547-24-000002","document":"wk-form4_1729714866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454724000002/wk-form4_1729714866.xml","form_type":"4"}},{"id":1487173,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-06-07T11:26:14.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of March 27,  2021."}],"balance_after":14000,"derivative":{"exercise_price":4,"expiration_date":"2027-03-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001895944-24-000011","document":"wk-form4_1717759566.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000189594424000011/wk-form4_1717759566.xml","form_type":"4"}},{"id":1487172,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2024-06-07T11:26:14.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":4,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Due to an inadvertent error, the Form 3 filed by the Reporting Person on June 29, 2023 incorrectly reported the amount of securities beneficially owned. This inadvertent error caused the amount of securities beneficially owned to be understated by 691 shares. The new amount reported in Column 5 reports the correct amount of securities beneficially owned following the reported transaction."}],"balance_after":6691,"source":{"system":"sec-edgar","filing":"0001895944-24-000011","document":"wk-form4_1717759566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000189594424000011/wk-form4_1717759566.xml","form_type":"4"}},{"id":1515756,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29477,"kind":"person","name":"DUBIN THOMAS I H","position":1,"cik":"0001231945","reported_name":"DUBIN THOMAS I H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-05-15T20:35:01.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to Mr. Dubin's continued service, in four equal annual installments beginning on May 14, 2024."}],"balance_after":50000,"derivative":{"exercise_price":4.42,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567264-24-000019","document":"wk-form4_1715805281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231945/000156726424000019/wk-form4_1715805281.xml","form_type":"4"}},{"id":1589413,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:06:55.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-24-020835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000121390024020835/ownership.xml","form_type":"4"}},{"id":1590082,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29601,"kind":"person","name":"Leahy Emer","position":1,"cik":"0001875180","reported_name":"Leahy Emer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:05:02.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024."}],"balance_after":50000,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-24-020834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875180/000121390024020834/ownership.xml","form_type":"4"}},{"id":1588852,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29472,"kind":"person","name":"GOLDBERG MARK A","position":1,"cik":"0001278042","reported_name":"GOLDBERG MARK A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:03:41.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024."}],"balance_after":50000,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-24-020832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1278042/000121390024020832/ownership.xml","form_type":"4"}},{"id":1589423,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29553,"kind":"person","name":"Donovan Daniel","position":1,"cik":"0001934188","reported_name":"Donovan Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:02:37.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024."}],"balance_after":50000,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-24-020831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1934188/000121390024020831/ownership.xml","form_type":"4"}},{"id":1588895,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:01:16.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":33574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested 100% on March 6, 2024."}],"balance_after":33574,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":33574},"source":{"system":"sec-edgar","filing":"0001213900-24-020830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000121390024020830/ownership.xml","form_type":"4"}},{"id":1588894,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:01:16.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":464805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024."}],"balance_after":464805,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":464805},"source":{"system":"sec-edgar","filing":"0001213900-24-020830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000121390024020830/ownership.xml","form_type":"4"}},{"id":1713703,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2023-12-12T13:17:04.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four equal, annual installments, beginning on December 11, 2024."}],"balance_after":80000,"derivative":{"exercise_price":6.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001213900-23-094886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000121390023094886/ownership.xml","form_type":"4"}},{"id":1825040,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29548,"kind":"person","name":"Wesolowski John M","position":1,"cik":"0001895944","reported_name":"Wesolowski John M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2023-07-21T20:11:06.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., according to the following schedule: 25% will vest on July 19, 2023, and the remaining 75% will vest in three, equal, annual installments, beginning on July 19, 2024."}],"balance_after":50000,"derivative":{"exercise_price":6.43,"expiration_date":"2033-07-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-23-058840","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895944/000121390023058840/ownership.xml","form_type":"4"}}]}